For people with psoriasis, the risk of cardiovascular disease is twice as high as it is for those without the disease. Psoriasis and some treatments also increase the risk of irregular heartbeat, stroke, high cholesterol and atherosclerosis.
Recently, researchers have found that anti-inflammatory biologic therapies used to treat moderate to severe psoriasis can significantly reduce coronary inflammation in patients with the chronic skin condition, while coronary inlfammation is associated with developing heart artery disease.
It's more than that, the treatment can also reduce coronary inflammation in patients with lupus, rheumatoid arthritis or other chronic inflammatory disease.